Xq26.3-q27.1 duplication including SOX3 gene in a Chinese boy with hypopituitarism: case report and two years treatment follow up.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794 (Electronic) Linking ISSN: 17558794 NLM ISO Abbreviation: BMC Med Genomics Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central
    • Subject Terms:
    • Abstract:
      Background: SOX3 is essential for pituitary development normally at the earliest stages of development. In humans, variants of SOX3 can cause X-linked hypopituitarism with various clinical manifestations, with or without mental retardation.
      Case Presentation: We present an 8-year-old Chinese patient with congenital hypopituitarism who had a 6.180 Mb duplication on Xq26.3q27.1 including SOX3, F9, and eight other contiguous genes. The main complains of the boy was short stature. His height was 90.1 cm (- 5.87SDS), weight 11.5 kg (- 5.25SDS). He developed growth hormone (GH) deficiency, cryptorchidism and low thyroid function. Pituitary magnetic resonance imaging revealed the pituitary dysplasia. After diagnosis, levothyroxine was given for one month first, and the thyroid function basically returned to normal, but the growth situation did not improve at all. Then recombinant human GH was given, his height, growth rate and height SDS were improved significantly in the 2 years follow-up. The level of height SDS improved from - 5.87 SDS before treatment to - 3.27 SDS after the first year of treatment and - 1.78 SDS after the second years of treatment. Gonadal function and long-term prognosis of the patient still need further observation and follow-up.
      Conclusions: This is the first case of Chinese male patient with multiple hypophysis dysfunction caused by SOX3 duplication, which will expand the range of phenotypes observed in patients with duplication of SOX3.
      (© 2022. The Author(s).)
    • References:
      Am J Med Genet A. 2013 May;161A(5):1137-42. (PMID: 23463539)
      Am J Hum Genet. 2005 May;76(5):833-49. (PMID: 15800844)
      Am J Hum Genet. 2002 Dec;71(6):1450-5. (PMID: 12428212)
      Horm Res Paediatr. 2019;92(6):382-389. (PMID: 31678974)
      Hormones (Athens). 2014 Oct-Dec;13(4):552-60. (PMID: 25402377)
      Eur J Endocrinol. 2007 Aug;157 Suppl 1:S3-14. (PMID: 17785694)
      Pituitary. 2014 Dec;17(6):569-74. (PMID: 24346842)
      J Clin Endocrinol Metab. 2014 Dec;99(12):E2702-8. (PMID: 25140394)
      Clin Endocrinol (Oxf). 2016 Oct;85(4):673-5. (PMID: 27260338)
      Nat Genet. 2004 Mar;36(3):247-55. (PMID: 14981518)
      Hum Genet. 2004 Oct;115(5):399-408. (PMID: 15338277)
      J Clin Invest. 2011 Jan;121(1):328-41. (PMID: 21183788)
      J Endocrinol. 2009 Mar;200(3):245-58. (PMID: 19074474)
      J Pediatr Endocrinol Metab. 2020 Mar 26;33(3):443-447. (PMID: 26352083)
      Am J Med Genet A. 2005 Sep 15;138(1):11-7. (PMID: 16097007)
      Am J Med Genet A. 2014 Aug;164A(8):1947-52. (PMID: 24737742)
      Clin Endocrinol (Oxf). 2005 Aug;63(2):121-30. (PMID: 16060904)
      Prenat Diagn. 2019 Oct;39(11):1026-1034. (PMID: 31299102)
      Am J Med Genet A. 2015 Jul;167(7):1676-8. (PMID: 25900196)
      Mol Cell Biol. 2003 Nov;23(22):8084-91. (PMID: 14585968)
    • Contributed Indexing:
      Keywords: Case report; Hypopituitarism; Recombinant human growth hormone; SOX3 duplication; Xq26.3-q27.1 duplication
    • Accession Number:
      0 (SOX3 protein, human)
      0 (SOXB1 Transcription Factors)
    • Publication Date:
      Date Created: 20220204 Date Completed: 20220407 Latest Revision: 20220407
    • Publication Date:
      20221213
    • Accession Number:
      PMC8811983
    • Accession Number:
      10.1186/s12920-022-01167-2
    • Accession Number:
      35114986